Besides the now approved remdesivir: Emerging options to treat Covid-19

Last Updated on

May 03, 2020 –  The world is desperate in the search for a treatment or better yet a vaccine in the Covid-19 pandemic. Slowly, there are some options emerging at least for the treatment of seriously ill Covid-19 patients. First of all,  the American Food and Drug Administration just issued an emergency use authorization (EUA) for the investigational antiviral drug remdesivir for the treatment of suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease. While there is limited information known about the safety and effectiveness of using remdesivir to treat people in the hospital with COVID-19, the investigational drug was shown in a clinical trial to shorten the time to recovery in some patients.

SARS-Cov-2 Interactome

Remdesivir is the first example of a candidate drug being repurposed towards treatment of Covid-19 disease from its original use in the treatment of the Ebola disease in the West African Ebola virus epidemic of 2013–2016 and also during the 2018  Kivu Ebola epidemic in the Democratic Republic of Congo.

Along these lines of repurposing drugs, early data on such efforts show that almost a dozen approved drugs could be effective against Covid-19 disease. Thus, according to a multidisciplinary study conducted by a large team of scientists in the United States and France that has just appeared in the Journal Nature, at least 10 different drug compounds ranging from cancer therapies to antipsychotics and antihistamines may be effective at preventing the SARS-CoV-2 from multiplying in the body.

The researchers mapped the human proteins SARS-CoV-2 interacts with inside the body when it infects cells and makes copies of itself, then looked for compounds that could block the virus from using those proteins, giving rise to a SARS-CoV-2 interactome. The result showed that 47 compounds in cell cultures had the desired effect, at least 10 of which are already in approved drugs or being studied for diverse conditions, but could be repurposed against COVID-19, the illness caused by SARS-CoV-2. In the study, candidates for repurposing included allergy medicine ingredients including clemastine, the antipsychotic haloperidol, and malaria drug hydroxychloroquine

Particularly the latter has stirred some controversy in the media and even among the clinical research community when it comes to a possible role of hydroxychloroquine as a treatment of Covid-19. Hydroxychloquine, sold, among others, under the brand name Plaquenil, is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquineOther indications include rheumatoid arthritis, lupus, and porphyria cutanea tarda. In all these indications, side effects include vomiting, headache, changes in vision, and muscle weakness as well as more serious effects such as   allergic reactions, vision problems, and heart problems. Nevertheless, and despite some controversial study results about effectiveness and safety, hydroxychchloroquine remains one of the options of a repurposed drug for Covid-19 treatment.

By means of the SARS-CoV-2 interactome approach in the present study, a number of additional compounds have been identified with the potential of effectivity in the treatment of Covid-19. These include the experimental chemical, PB28, was 20-times more potent than hydroxychloroquine in targeting the cellular receptor for SARS-CoV-2, the hormone progesterone, and the antiviral plitidepsin, the pharmacologically active ingredient in Madrid-based PharmaMar’s experimental cancer therapy Aplidin. There are some interesting notions to these compounds. First, Plitidepsin is currently already being tested in Covid-19 trials in Spain. Secondly, Progesterone may help to explain some aspects of the fact that men seem more often affected than women and often show more serious disease progressions. And last but not least, the experimental chemical PB28 exhibited significantly less affinity than hydroxychloroquine for a heart protein which may be at the root for the known heart toxicity of hydroxychloroquine in some patients.

Some of the drugs and compounds tested in the researchers SARS-CoV-2 interactome approach have turned out, at least in the  laboratory setting, many times more potent than remdesivir. All these compound may be candidates for repurposing after thorough further in vitro and in vivo (i.e., clinical) development.

See here a sequence on how current drugs are being repurposed to possibly fight coronavirus (Covid-19):

Print Friendly, PDF & Email

Tags: , , , , , , , , , , , , , , , , ,
About the Author
Joseph Gut - thasso Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion


No comments yet

thasso: conditions

thasso: newest tweets

thasso: recent comments

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Scientists identify gene linked to thinness that may help resist weight gain May 21, 2020
    While others may be dieting and hitting the gym hard to stay in shape, some people stay slim effortlessly no matter what they eat. In a study publishing May 21 in the journal Cell, researchers use a genetic database of more than 47,000 people in Estonia to identify a gene linked to thinness that may […]
  • Tracking the COVID-19 pandemic in Australia using genomics May 21, 2020
    Using genome sequencing to identify genetic mutations in SARS-CoV-2 cases in Victoria, researchers have identified clusters and transmission networks which has helped limit the spread of the virus, painting an important picture of transmission in Victoria.
  • COVID-19 study looks at genetics of healthy people who develop severe illness May 21, 2020
    To help unravel the mysteries of COVID-19, scientists are sequencing the DNA of young, healthy adults and children who develop severe illness despite having no underlying medical problems. The researchers are looking for genetic defects that could put certain individuals at high risk of becoming severely ill from the novel coronavirus.
  • Scientists discover more than 200 genetic factors that cause heart arrhythmia May 21, 2020
    Hundreds of new links have been found between people's DNA and the heart's electrical activity, according to a study of almost 300,000 people led by researchers at Queen Mary University of London and the Broad Institute of MIT and Harvard.
  • Weight loss surgery may alter gene expression in fat tissue May 21, 2020
    Altered gene expression in fat tissue may help explain why individuals who have regained weight after weight loss surgery still experience benefits such as metabolic improvements and a reduced risk of type 2 diabetes. The findings come from a study published in the Journal of Internal Medicine.
  • New studies reveal extent and risks of laughing gas & stimulant abuse among young people May 23, 2020
    In one study, researchers from Turkey reported increasing stimulant use among medical students approaching their final exams, despite the substantial risks to their health. In the second study, researchers from the Netherlands detailed the neurological outcomes associated with recreational use of laughing gas (nitrous oxide), suggesting that, for some individuals, permanent neurological damage can occur.
  • Sleep-wake disturbances can predict recurrent events in stroke survivors May 23, 2020
    The study, conducted in Switzerland, found that having multiple sleep-wake disturbances such as sleep-disordered breathing, extreme long or short sleep duration, insomnia and restless leg syndrome independently and significantly increased the risk of a new cardio-cerebrovascular event in the two years following a stroke.
  • Does MRI have an environmental impact? May 23, 2020
    Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly […]
  • New native grass species have been discovered on the Iberian Peninsula and Menorca May 22, 2020
    The new species belong to the genus Aira, delicate herbaceous plants, which enjoy their greatest diversity in the Mediterranean Region. One of them, Aira minoricensis is a native species of the siliceous sands of Menorca. The other new species is called Aira hercynica and is widely found in the area of the Iberia Peninsula which […]
  • Combinatorial screening approach opens path to better-quality joint cartilage May 22, 2020
    High-throughput platform identifies complex conditions with biomaterial compositions, and mechanical and chemical stimuli that help stem cells produce more robust cartilage.